Pubblicazioni Scientifiche

Ricerca su tutti i campi

Ricerca avanzata

Tipo pubbl.	Pubblicazione
Randomized Controlled Trial; Multicenter Study	Knauf W U, Lissitchkov T, Aldaoud A, Liberati A M, Loscertales J, Herbrecht R, Juliusson G, Postner G, Gercheva L, Goranov S, Becker M, Fricke H -J, Huguet F, Del Giudice I, Klein P, Merkle K, Montillo M Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: Updated results of a randomized phase III trial Br J Haematol 2012;159(1):67-77.
Research Support	Knoebl P, Marco P, Baudo F, Collins P, Huth-Kuhne A, Nemes L, Pellegrini F, Tengborn L, Levesque H Demographic and clinical data in acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2) J Thromb Haemost 2012;10(4):622-631.
Conference Abstract	Lampertico P, Soffredini R, Invernizzi F, Vigano M, Facchetti F, Minola E, Fracassetti O, Suter F, Zaltron S, Vavassori A, Carosi G, Angeli E, Gubertini G, Magni C, Testa A, Antonucci G, Vinci M, Pinzello G, Fatta E, Fargion S, Del Poggio P, Coco B, Brune Maintained viral suppression and excellent safety profile of entecavir monotherapy in 418 nuc-naive patients with chronic hepatitis B: A 4-year field practice, multicenter study J Hepatol 2012;56( Suppl 2):S206-S207.
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Minola E, Cologni G, Rizzi M, Zaltron S, Vavassori A, Carosi G, Angeli E, Gubertini G A, Magni C F, Rizzardini G, Testa A, D'Offizi G, Vinci M, Pinzello G, Fatta E, Fargion S, Colombo S, Fracassetti O, Del Poggio P, Coco B, Brunetto M R, Andreoletti M, Colli A, Fasano M, Santantonio T A, Colloredo G, Pasulo L, Fagiuoli S, Colombo A E, Bellati G A, Milanese M, Terreni N M, Quagliuolo M, Lunghi G, Facchetti F, Invernizzi F, Colombo M Entecavir treatment for NUC naive, field practice patients with chronic hepatitis B: Excellent viral suppression and safety profile over 5 years of treatment Hepatology 2012;56(Suppl 1):370A-371A.
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Yurdaydin C, Idilman R, Papatheodoridis G V, Margariti K, Buti M, Esteban R, Zaltron S, Vavassori A, Carosi G, Minola E, Vinci M, Pinzello G, Giorgini A M, Zuin M, Salmi A, Del Poggio P, De Filippi F, Bruno S, Pasul 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: A multicenter European study in clinical practice Dig Liver Dis 2012;44( Suppl 1):S16-S17.
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Yurdaydin C, Idilman R, Papatheodoridis G V, Margariti K, Buti M, Esteban R, Zaltron S, Vavassori A, Minola E, Vinci M, Pinzello G, Giorgini A M, Zuin M, Salmi A, Colombo S, Fracassetti O, Del Poggio P, Bruno S, Pasulo L, Fagiuoli S, Andreoletti M, Colli A, Maldini F F, Milanese M, Strazzabosco M, Colombo A E, Bellati G A, Angeli E, Magni C F, Gubertini G A, Fasano M, Santantonio T, Terreni N M, Spinzi G, Facchetti F, Invernizzi F, Colombo M Tenofovir monotherapy suppressed viral suppression in most field practice, treatment-naive patients with chronic hepatitis B followed for 3 years in a multicenter European study Hepatology 2012;56(Suppl 1):389A- .
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Yurdaydin C, Idilman R, Papatheodoridis G, Ekaterini M, Buti M, Esteban R, Zaltron S, Vavassori A, Carosi G, Minola E, Vinci M, Pinzello G, Giorgini A, Zuin M, Salmi A, Del Poggio P, De Filippi F, Bruno S, Pasulo L, F Tenofovir monotherapy for naive patients with chronic hepatitis B: A multicenter european study in clinical practice in 302 patients followed for 30 months J Hepatol 2012;56( Suppl 2):S208- .
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Yurdaydin C, Idilman R, Papatheodoris G, Margheriti K, Buti M, Esteban R, Zaltron S, Vavassori A, Carosi G, Minola E, Vinci M, Pinzello G, Giorgini A, Zuin M, Salmi A, Del Poggio P, De Filippi F, Bruno S, Pasulo L, Fagiuoli S, Andreoletti M, Colli A, Fumagalli Maldini F, Milanese M, Colombo A E, Bellati G A, Angeli E, Magni C, Gubertini G, Rizzardini G, Fasano M, Santantonio T, Terreni N, Spinzi G, Facchetti F, Invernizzi F, Colombo M 2-year effectiveness and safety of tenofovir in 302 NUC-naive patients with chronic hepatitis B: A multicenter European study in clinical practice Dig Liver Dis 2012;44(Suppl 2):S70- .
Conference Abstract	Lampertico P, Vigano M, Soffredini R, Facchetti F, Minola E, Fracassetti O, Suter F, Zaltron S, Vavassori A, Carosi G, Angeli E, Gubertini G A, Magni C F, Testa A, Antonucci G, Vinci M, Pinzello G, Fatta E, Fargion S, Del Poggio P, Coco B, Brunetto M R, Andreoletti M, Colli A, Fasano M, Santantonio T, Colloredo G, Pasulo L, Fagiuoli S, Colombo A, Bellati G A, Fumagalli Maldini F, Milanese M, Pozzi M, Terreni N M, Spinzi G, Quagliuolo M, Quagliuolo M, Lunghi G, Colombo M Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis B from field practice: High efficacy and favorable safety profile over 3 years of treatment Dig Liver Dis 2012;44(Suppl 1):S16- .
Conference Abstract	Lampertico P, Vigano M, Soffredini R, Facchetti F, Minola E, Fracassetti O, Suter F, Zaltron S, Vavassori A, Carosi G, Angeli E, Gubertini G, Magni C, Testa A, Antonucci G, Vinci M, Pinzello G, Fatta E, Fargion S, Del Poggio P, Coco B, Brunetto M R, Andr Entecavir monotherapy in 418 NUC-naive patients with chronic hepatitis b from field practice: High efficacy and favorable safety profile over 3 years of treatment Dig Liver Dis 2012;44( Suppl 2):S184-S185.
Conference Abstract	Landolina M, Lunati M, Perego G B, Curnis A, Guenzati G, Vicentini A, Borghi G, Zanaboni P, Bisetti S, Marzegalli M Remote monitoring in heart failure patients with implantable defibrillator: Reduces healthcare utilization and improves quality of care Eur Heart J 2012;33(Suppl 1):994-995.
Conference Abstract	Landolina M, Perego G B, Lunati M, Curnis A, Guenzati G, Rordorf R, Balla E, Borghi G, Zanaboni P, Valsecchi S, Bisetti S, Marzegalli M Remote monitoring reduces healthcare utilization and improves quality of care in heart failure patients with implantable defibrillator: the evolvo study G Ital Cardiol 2012;13(5 Suppl 2):81S- .
Randomized Controlled Trial; Multicenter Study	Landolina M, Perego G B, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study Circulation 2012;125(24):2985-2992.
Clinical Trial; Prospective Studies	Larocca A, Cavallo F, Bringhen S, Di Raimondo F, Falanga A, Evangelista A, Cavalli M, Stanevsky A, Corradini P, Pezzatti S, Patriarca F, Cavo M, Peccatori J, Catalano L, Carella A M, Cafro A M, Siniscalchi A, Crippa C, Petrucci M T, Yehuda D B, Beggia Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide Blood 2012;119(4):933-939.
Restrospective Studies	Liava A, Francione S, Tassi L, Lo Russo G, Cossu M, Mai R, Darra F, Fontana E, Dalla Bernardina B Individually tailored extratemporal epilepsy surgery in children: anatomo-electro-clinical features and outcome predictors in a population of 53 cases Epilepsy Behav 2012;25(1):68-80.
Meta-Analysis; Review	Lipton A, Fizazi K, Stopeck A T, Henry D H, Brown J E, Yardley D A, Richardson G E, Siena S, Maroto P, Clemens M, Bilynskyy B, Charu V, Beuzeboc P, Rader M, Viniegra M, Saad F, Ke C, Braun A, Jun S Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials Eur J Cancer 2012;48(16):3082-3092.
Conference Abstract	Lo-Coco F, Avvisati G, Orlando S M, Ferrara F, Vignetti M, Fazi P, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih H R, Brandts C H, Morra E, Von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lubbert M, Hanel M, Schmitz N, Link H, Kropp M G, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Sauer M, Dohner H, Ganser A, Mandelli F, Ehninger G, Amadori S, Thiede C, Schlenk R F, Platzbecker U Atra and arsenic trioxide (ATO) versus atra and idarubicin (AIDA) for newly diagnosed, non high-risk acute promyelocytic leukemia (APL): Results of the phase III, prospective, randomized, intergroup APL0406 study by the italian-german cooperative groups g Blood 2012;120(21): - .
Journal Article	Locati E T, Vargiu S, Mulargia E, Ardito C, Schirru M, Pedretti S, Negrini F, Lunati M New implantable devices for patient management: role and perspectives of remote monitoring of implantable cardioverter-defibrillators G Ital Cardiol (Rome) 2012;13(10 Suppl 2):36S-40S.
Conference Abstract	Loi G, Meloni A, Melis G B, Deiana S, Diaz G, Ferrazzi E, Ragusa A How long is the latent phase of labour? BJOG Int J Obstet Gynaecol 2012;119(Suppl 1):12- .
Conference Abstract	Loi G, Meloni A, Melis G B, Deiana S, Diaz G, Ferrazzi E, Ragusa A Diagnosis of labour: the II prospective clinical study BJOG Int J Obstet Gynaecol 2012;119( Suppl 1):52- .

Risultati da 4001 a 4020 di 6391 totali

Precedente -

- Successiva

AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA | Piazza Ospedale Maggiore 3 | 20162 Milano | t. +39 02 6444.1 - f. +39 02 6420901 | CF e Partita IVA: 11390840152